Homozygous CNP Mutation and Neurodegeneration in Weimaraners: Myelin Abnormalities and Accumulation of Lipofuscin-like Inclusions

Stefan H. Keller,Gary S. Johnson,Garrett Bullock,Tendai Mhlanga-Mutangadura,Malte Schwartz,Savannah G. Pattridge,Juyuan Guo,Gregg D. Kortz,Martin L. Katz
DOI: https://doi.org/10.3390/genes15020246
IF: 4.141
2024-02-16
Genes
Abstract:A progressive neurological disorder was observed in a male neutered Weimaraner. Clinical signs included fecal incontinence, lethargy, moderate paraparesis, proprioceptive pelvic limb ataxia, falling, cognitive decline, incoordination, decreased interest in food, changes in posture, and episodes of trance-like behavior. Neurologic signs were first observed at approximately 4 years, 10 months of age and progressed slowly. Magnetic resonance imaging showed generalized brain atrophy with areas of white matter pathology. Humane euthanasia was elected at 6 years, 7 months of age due to increasing severity of the neurological signs. Autofluorescent intracellular granules were observed in the cerebral and cerebellar cortexes, optic nerve, and cardiac muscle of the affected dog. These abnormal inclusions in the cerebral cortex and cardiac muscle immunolabeled with antibodies to mitochondrial ATP synthase subunit c protein, like that observed in the neuronal ceroid lipofuscinosis group of lysosomal storage diseases. Immunolabeling also demonstrated pronounced neuroinflammation in brain tissues. The ultrastructural appearances of the disease-related inclusion bodies in the brain and optic nerve were quite variable. The ultrastructure and locations of many of the inclusions in the nervous tissues suggested that they were derived, at least in part, from the myelin surrounding axons. The storage bodies in the cardiac muscle were located in mitochondria-rich regions and consisted of parallel arrays of membrane-like components interspersed with electron-dense flocculent material. The disease was characterized by pronounced abnormalities in the myelin of the brain and optic nerve consisting of distinctive areas of ballooning between the layers of myelin. The whole genome sequence generated from the affected dog contained a homozygous G-to-A missense mutation in CNP, which encodes proteins with CNPase enzyme activity and a structural role in myelin. The mutation predicts a Thr42Met amino acid sequence substitution. Genotyping of archived Weimaraner DNA samples identified an additional G > A variant homozygote with a clinical history and brain lesions similar to those of the proband. Of 304 Weimaraners and over 4000 other dogs of various breeds, the proband and the other Weimaraner that exhibited similar signs were the only two that were homozygous for the CNP missense variant. CNPase immunolabeling was widespread in brain tissues from normal dogs but was undetectable in the same tissues from the proband. Based on the clinical history, fluorescence and electron-microscopy, immunohistochemistry, and molecular genetic findings, the late-onset Weimaraner disorder likely results from the missense mutation that results in CNPase deficiency, leading to myelin abnormalities, accumulation of lysosomal storage bodies, and brain atrophy. Similar disorders have been associated with different CNP variants in Dalmatians and in human subjects.
genetics & heredity
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore a progressive neurodegenerative disease in Weimaraners caused by a homologous CNP gene mutation. Specifically, the research aims to: 1. **Describe clinical symptoms**: The paper details a series of neurological symptoms that began in a neutered male Weimaraner at approximately 4 years and 10 months of age, including fecal incontinence, listlessness, mild hind - limb paralysis, limb ataxia, falls, cognitive decline, coordination disorders, loss of appetite, postural changes, and trance - like behavioral episodes. 2. **Imaging features**: Widespread atrophy of the brain was observed by magnetic resonance imaging (MRI), accompanied by white - matter pathological changes. 3. **Histological and cytological analysis**: Intracellular granules with autofluorescence were observed in the cerebral cortex, cerebellar cortex, optic nerve, and myocardium of the affected dogs. These abnormal inclusions were immunolabeled by antibodies to the mitochondrial ATP synthase subunit c protein in the cerebral cortex and myocardium, similar to lysosomal storage diseases in the neuronal ceroid lipofuscinosis (NCL) group. 4. **Molecular genetic analysis**: Through whole - genome sequencing of the affected dog, a homologous G - to - A missense mutation in the CNP gene was discovered, which results in the substitution of threonine at position 42 with methionine (Thr42Met). In addition, through genotyping of archived Weimaraner DNA samples, another homozygote of the homologous G - to - A variant with a similar clinical history and brain lesions was found. 5. **Pathological mechanism**: Based on the clinical history, fluorescence microscopy, electron microscopy, immunohistochemistry, and molecular genetic results, the study suggests that this late - onset Weimaraner disease may be due to CNPase deficiency, which in turn causes myelin sheath abnormalities, the accumulation of lysosomal storage bodies, and brain atrophy. Overall, through multi - faceted analysis, this paper reveals the relationship between CNP gene mutations and a specific neurodegenerative disease in Weimaraners, providing important clues for understanding the pathogenesis of this disease.